Cofactor Genomics

Saint Louis, MO · Privately Held (backing)

Developer of a precision diagnostic assay designed to predict immune responses in oncology. Cofactor Genomics is based in Saint Louis, MO. It was valued at $41.9 million at its later-stage round in Dec 2021, the last priced event on record. It has raised $28.7 million across 2 recorded rounds; the latest was a $6.9 million early-stage round in Dec 2021.

PMV mark · valuation
$41.9M
Oct 2026
Priced at
its later-stage round
Dec 2021
Total raised
$28.7M
Last round
Early Stage VC
Dec 2021
What is Cofactor Genomics worth?
$41.9MPrivateMarketView mark · Oct 2026

Valued at $41.9M at its later-stage round, Dec 2021. Nothing has traded since.

Free account
More of Cofactor Genomics with a free account
  • ·The complete investor list: 30 names
  • ·Watch Cofactor Genomics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Cofactor Genomics funding history

2 rounds
DateRoundRaisedPost-money
Dec 2021Early Stage VC$6.9M▮
Jun 2017Early Stage VC$10.7M▮
Unlock post-money valuations

Membership and data by Private Market View

Cofactor Genomics valuation

Cofactor Genomics was valued at $41.9 million at its later-stage round in Dec 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Cofactor Genomics raised?

Cofactor Genomics has raised $28.7 million in total; 2 of its rounds are on record. The largest on record was a $6.9 million early-stage round in Dec 2021.

Cofactor Genomics has filed 2 Form Ds with the SEC since 2017, most recently in Dec 2021 ($6.9 million sold to 9 investors).

How Cofactor Genomics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Cofactor Genomics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Cofactor Genomics

What is Cofactor Genomics worth?
Cofactor Genomics is valued at $41.9M as of Oct 2026. Valued at $41.9M at its later-stage round, Dec 2021. Nothing has traded since.
How much has Cofactor Genomics raised?
Cofactor Genomics has raised $28.7M in total funding across 2 recorded rounds.
When did Cofactor Genomics last raise?
Cofactor Genomics last raised in Dec 2021 (Early Stage VC), raising $6.9M.